Bagaimana Laporan Keuangan Organisasi Nirlaba

Tujuan utama laporan keuangan organisasi nirlaba adalah menyediakan informasi yang relevan untuk memenuhi kepentingan para penyumbang, anggota organisasi, kreditur, dan pihak lain yang menyediakan sumber daya bagi organisasi nirlaba.

Tujuan laporan keuangan, termasuk catatan atas laporan keuangan, adalah untuk menyajikan informasi mengenai:

1. Jumlah dan sifat aktiva, kewajiban, dan aktiva bersih suatu organisasi organisasi.
2. Pengaruh transaksi, peristiwa dan situasi lainnya yang mengubah nilai dan sifata ktiva bersih.
3. Jenis dan jumlah arus masuk dan arus keluar sumber daya.
4. Jenis dan jumlah arus masuk dan arus keluar sumber daya dalam satu periode dan hubungan antara keduanya.
5. Cara suatu organisasi mendapatkan dan membelanjakan kas, memperoleh pinjaman dan melunasi pinjaman, dan factor lainnya yang berpengaruh pada likuiditasnya.truly mixed emotions that I announce the departure of Philip E. Bourne, Ph.D., who will be leaving his post as NIH’s first Associate Director for Data Science to become the Stephenson Chair of Data Science, Director of the Data Science Institute, and Professor in the Department of Biomedical Engineering at the University of Virginia, Charlottesville.  I am happy for Phil to have this exceptional opportunity, and know that UVA will be well served by his depth of knowledge in data science.  At the same time, I am saddened that NIH will be losing his prowess and passion for tackling the opportunities and challenges of our increasingly data-driven biomedical research enterprise.

The group is part of the Hepatic Vascul

Phil will remain at NIH through April 30, 2017, and National Library of Medicine Director Patricia Flatley Brennan, R.N., Ph.D., will serve as Interim Associate Director for Data Science until a new appointment is made.

The group is part of the Hepatic Vascular Cell Signaling Lab and Hepatocellular Carcinoma Lab programs as a major initiative involves collaboration with scientists to establish translational research.The activities of the Advanced Liver Diseases Study Group span from population-based research that utilizes the extensive resources of the Rochester Epidemiology Project to vascular endothelial pathophysiology.

The mission of the Advanced Liver Diseases Study Group is to become the premier epidemiology, clinical, translational research, and treatment center for advanced liver diseases, cirrhosis, and portal hypertension in the world.

[/padding]